{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:28:08Z","timestamp":1769635688106,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:00:00Z","timestamp":1361491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00134-013-2863-6","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T13:07:40Z","timestamp":1361452060000},"page":"811-822","source":"Crossref","is-referenced-by-count":71,"title":["Randomised trials of 6\u00a0% tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Amit","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umeer","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,22]]},"reference":[{"key":"2863_CR1","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/cc9293","volume":"14","author":"S Finfer","year":"2010","unstructured":"Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J (2010) Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 14:R185","journal-title":"Crit Care"},{"key":"2863_CR2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1399-6576.2008.01690.x","volume":"52","author":"FS Investigators","year":"2008","unstructured":"Investigators FS, Trials SCC (2008) Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand 52:750\u2013758","journal-title":"Acta Anaesthesiol Scand"},{"key":"2863_CR3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901\u20131911","journal-title":"N Engl J Med"},{"key":"2863_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1213\/ANE.0b013e31820ad607","volume":"112","author":"CS Hartog","year":"2011","unstructured":"Hartog CS, Kohl M, Reinhart K (2011) A systematic review of third-generation hydroxyethyl starch (HES 130\/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 112:635\u2013645","journal-title":"Anesth Analg"},{"key":"2863_CR5","first-page":"w13656","volume":"142","author":"CJ Wiedermann","year":"2012","unstructured":"Wiedermann CJ, Joannidis M (2012) Mortality after hydroxyethyl starch 130\/0.4 infusion: an updated meta-analysis of randomized trials. Swiss Med Wkly 142:w13656","journal-title":"Swiss Med Wkly"},{"key":"2863_CR6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00134-012-2614-0","volume":"38","author":"CS Hartog","year":"2012","unstructured":"Hartog CS, Skupin H, Natanson C, Sun J, Reinhart K (2012) Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Med 38:1258\u20131271","journal-title":"Intensive Care Med"},{"key":"2863_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00134-012-2472-9","volume":"38","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS, European Society of Intensive Care M (2012) Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 38:368\u2013383","journal-title":"Intensive Care Med"},{"key":"2863_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125\u2013139","journal-title":"N Engl J Med"},{"key":"2863_CR9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","volume":"357","author":"F Schortgen","year":"2001","unstructured":"Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911\u2013916","journal-title":"Lancet"},{"key":"2863_CR10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e31820ad3b7","volume":"112","author":"SL Shafer","year":"2011","unstructured":"Shafer SL (2011) Shadow of doubt. Anesth Analg 112:498\u2013500","journal-title":"Anesth Analg"},{"key":"2863_CR11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1213\/ANE.0b013e3182099c49","volume":"112","author":"K Reinhart","year":"2011","unstructured":"Reinhart K, Takala J (2011) Hydroxyethyl starches: what do we still know? Anesth Analg 112:507\u2013511","journal-title":"Anesth Analg"},{"key":"2863_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-227X-8-1","volume":"8","author":"CJ Wiedermann","year":"2008","unstructured":"Wiedermann CJ (2008) Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8:1","journal-title":"BMC Emerg Med"},{"key":"2863_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1213\/ANE.0b013e318236b4d6","volume":"114","author":"DJ Gattas","year":"2012","unstructured":"Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S (2012) Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 114:159\u2013169","journal-title":"Anesth Analg"},{"key":"2863_CR14","doi-asserted-by":"crossref","unstructured":"Bunn F, Trivedi D (2012) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 6:CD001319","DOI":"10.1002\/14651858.CD001319.pub4"},{"key":"2863_CR15","doi-asserted-by":"crossref","unstructured":"Perel P, Roberts I (2012) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 6:CD000567","DOI":"10.1002\/14651858.CD000567.pub5"},{"key":"2863_CR16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM197809282991304","volume":"299","author":"JA Freiman","year":"1978","unstructured":"Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR (1978) The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 \u201cnegative\u201d trials. N Engl J Med 299:690\u2013694","journal-title":"N Engl J Med"},{"key":"2863_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-200307000-00010","volume":"99","author":"SM Kasper","year":"2003","unstructured":"Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, Diefenbach C (2003) Large-dose hydroxyethyl starch 130\/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200\/0.5 at recommended doses. Anesthesiology 99:42\u201347","journal-title":"Anesthesiology"},{"key":"2863_CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1213\/ane.0b013e31817e6eac","volume":"107","author":"SA Kozek-Langenecker","year":"2008","unstructured":"Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P (2008) The effects of hydroxyethyl starch 130\/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 107:382\u2013390","journal-title":"Anesth Analg"},{"key":"2863_CR19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1213\/01.ANE.0000061582.09963.FD","volume":"96","author":"TA Neff","year":"2003","unstructured":"Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R (2003) Repetitive large-dose infusion of the novel hydroxyethyl starch 130\/0.4 in patients with severe head injury. Anesth Analg 96:1453\u20131459 table of contents","journal-title":"Anesth Analg"},{"key":"2863_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/145749690809700310","volume":"97","author":"T Niemi","year":"2008","unstructured":"Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R (2008) Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 97:259\u2013265","journal-title":"Scand J Surg"},{"key":"2863_CR21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ane.0b013e31818c1282","volume":"108","author":"AA Schramko","year":"2009","unstructured":"Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT (2009) Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 108:30\u201336","journal-title":"Anesth Analg"},{"key":"2863_CR22","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055\u20132064","journal-title":"N Engl J Med"},{"key":"2863_CR23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"2863_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111\u2013124","journal-title":"N Engl J Med"},{"key":"2863_CR25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J (2012) Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med 367:124\u2013134","journal-title":"N Engl J Med"},{"key":"2863_CR26","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc11358","volume":"16","author":"B Guidet","year":"2012","unstructured":"Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H (2012) Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 16:R94","journal-title":"Crit Care"},{"key":"2863_CR27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00003246-200104000-00039","volume":"29","author":"J Cohen","year":"2001","unstructured":"Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S (2001) New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29:880\u2013886","journal-title":"Crit Care Med"},{"key":"2863_CR28","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"2863_CR29","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Workgroup A (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204\u2013R212","journal-title":"Crit Care"},{"key":"2863_CR30","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1001\/jama.1993.03500210049030","volume":"269","author":"DJ Cook","year":"1993","unstructured":"Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, McIlroy W, Oxman AD (1993) Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 269:2749\u20132753","journal-title":"JAMA"},{"key":"2863_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17\u201360","journal-title":"Intensive Care Med"},{"key":"2863_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2307\/3150969","volume":"18","author":"AG Sawyer","year":"1981","unstructured":"Sawyer AG, Ball AD (1981) Statistical power and effect size in marketing-research. J Marketing Res 18:275\u2013290","journal-title":"J Marketing Res"},{"key":"2863_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<1::AID-SIM134>3.0.CO;2-E","volume":"15","author":"H Sahai","year":"1996","unstructured":"Sahai H, Khurshid A (1996) Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med 15:1\u201321","journal-title":"Stat Med"},{"key":"2863_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1207\/s15328031us0304_1","volume":"3","author":"AJ Onwuegbuzie","year":"2004","unstructured":"Onwuegbuzie AJ, Leech NL (2004) Post hoc power: a concept whose time has come. Underst Stat 3:201\u2013230","journal-title":"Underst Stat"},{"key":"2863_CR35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE\u00a0II: a severity of disease classification system. Crit Care Med 13:818\u2013829","journal-title":"Crit Care Med"},{"key":"2863_CR36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"2863_CR37","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"2863_CR38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"2863_CR39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"2863_CR40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"2863_CR41","first-page":"1622","volume":"56","author":"M Dolecek","year":"2009","unstructured":"Dolecek M, Svoboda P, Kantorova I, Scheer P, Sas I, Bibrova J, Radvanova J, Radvan M (2009) Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology 56:1622\u20131628","journal-title":"Hepatogastroenterology"},{"key":"2863_CR42","first-page":"655","volume":"72","author":"D Palumbo","year":"2006","unstructured":"Palumbo D, Servillo G, D\u2019Amato L, Volpe ML, Capogrosso G, De Robertis E, Piazza O, Tufano R (2006) The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 72:655\u2013664","journal-title":"Minerva Anestesiol"},{"key":"2863_CR43","doi-asserted-by":"crossref","first-page":"659 e1","DOI":"10.1016\/j.jcrc.2010.04.007","volume":"25","author":"A Dubin","year":"2010","unstructured":"Dubin A, Pozo MO, Casabella CA, Murias G, Palizas F Jr, Moseinco MC, Kanoore Edul VS, Palizas F, Estenssoro E, Ince C (2010) Comparison of 6% hydroxyethyl starch 130\/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 25:659 e1\u2013659 e8","journal-title":"J Crit Care"},{"key":"2863_CR44","first-page":"38","volume":"24","author":"J Lv","year":"2012","unstructured":"Lv J, Zhao HY, Liu F, An YZ (2012) [The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 24:38\u201341","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2863_CR45","first-page":"150","volume":"23","author":"GC Zhu","year":"2011","unstructured":"Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT (2011) [The study of hypertonic saline and hydroxyethyl starch treating severe sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23:150\u2013153","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2863_CR46","first-page":"472","volume":"20","author":"F Li","year":"2008","unstructured":"Li F, Sun H, Han XD (2008) [The effect of different fluids on early fluid resuscitation in septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20:472\u2013475","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2863_CR47","unstructured":"Protsenko DN, Leiderman IN, Grigor\u2019ev EV, Kokarev EA, Levit AL, Gel\u2019fand BR (2009) [Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study]. Anesteziologiia i reanimatologiia: 9\u201313"},{"key":"2863_CR48","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/cc6812","volume":"12","author":"M Jacob","year":"2008","unstructured":"Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M (2008) Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 12:R34","journal-title":"Crit Care"},{"key":"2863_CR49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-010-2117-9","volume":"37","author":"Committee TCvHSTCM","year":"2011","unstructured":"Committee TCvHSTCM (2011) The crystalloid versus hydroxyethyl starch trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130\/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 37:816\u2013823","journal-title":"Intensive Care Med"},{"key":"2863_CR50","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/cc11673","volume":"16","author":"CS Hartog","year":"2012","unstructured":"Hartog CS, Reinhart K (2012) CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients. Crit Care 16:454","journal-title":"Crit Care"},{"key":"2863_CR51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bpa.2008.11.001","volume":"23","author":"C Ertmer","year":"2009","unstructured":"Ertmer C, Rehberg S, Van Aken H, Westphal M (2009) Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 23:193\u2013212","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2863_CR52","first-page":"9","volume":"26","author":"SH Sahin","year":"2009","unstructured":"Sahin SH, Memis D, Sut N (2009) High C-Reactive protein and amylase levels as prognostic markers in non-pancreatic severe sepsis patients. Trak Univ Tip Fak De 26:9\u201317","journal-title":"Trak Univ Tip Fak De"},{"key":"2863_CR53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11594700-000000000-00000","volume":"51","author":"R Bellmann","year":"2012","unstructured":"Bellmann R, Feistritzer C, Wiedermann CJ (2012) Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch. Clin Pharmacokinet 51:225\u2013236","journal-title":"Clin Pharmacokinet"},{"key":"2863_CR54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00508-011-1532-4","volume":"123","author":"CS Hartog","year":"2011","unstructured":"Hartog CS, Brunkhorst FM, Engel C, Meier-Hellmann A, Ragaller M, Welte T, Kuhnt E, Reinhart K (2011) Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use? Wien Klin Wochenschr 123:145\u2013155","journal-title":"Wien Klin Wochenschr"},{"key":"2863_CR55","doi-asserted-by":"crossref","unstructured":"Dart AB, Mutter TC, Ruth CA, Taback SP (2010) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Db Syst Rev","DOI":"10.1002\/14651858.CD007594.pub2"},{"key":"2863_CR56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.anes.0000296070.75956.40","volume":"108","author":"JL Vincent","year":"2008","unstructured":"Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P (2008) Are blood transfusions associated with greater mortality rates? Results of the sepsis occurrence in acutely ill patients study. Anesthesiology 108:31\u201339","journal-title":"Anesthesiology"},{"key":"2863_CR57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MBC.0b013e328338db67","volume":"21","author":"P Matsota","year":"2010","unstructured":"Matsota P, Politou M, Kalimeris K, Apostolaki S, Merkouri E, Gialeraki A, Travlou A, Kostopanagiotou G (2010) Do different substitution patterns or plant origin in hydroxyethyl starches affect blood coagulation in vitro? Blood Coagul Fibrin 21:448\u2013451","journal-title":"Blood Coagul Fibrin"},{"key":"2863_CR58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/bja\/ael019","volume":"96","author":"I Roten von","year":"2006","unstructured":"von Roten I, Madjdpour C, Frascarolo P, Burmeister MA, Fisch A, Schramm S, Bombeli T, Spahn DR (2006) Molar substitution and C2\/C6 ratio of hydroxyethyl starch: influence on blood coagulation. Br J Anaesth 96:455\u2013463","journal-title":"Br J Anaesth"},{"key":"2863_CR59","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1399-6576.2005.00733.x","volume":"49","author":"VG Nielsen","year":"2005","unstructured":"Nielsen VG (2005) Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 49:1163\u20131171","journal-title":"Acta Anaesthesiol Scand"},{"key":"2863_CR60","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1186\/cc8223","volume":"13","author":"M Sossdorf","year":"2009","unstructured":"Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Losche W (2009) HES 130\/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 13:R208","journal-title":"Crit Care"},{"key":"2863_CR61","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1399-6576.2010.02306.x","volume":"54","author":"A Godier","year":"2010","unstructured":"Godier A, Durand M, Smadja D, Jeandel T, Emmerich J, Samama CM (2010) Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference? Acta Anaesthesiol Scand 54:1241\u20131247","journal-title":"Acta Anaesthesiol Scand"},{"key":"2863_CR62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/bja\/82.4.510","volume":"82","author":"C Sirtl","year":"1999","unstructured":"Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510\u2013515","journal-title":"Br J Anaesth"},{"key":"2863_CR63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004410000324","volume":"304","author":"S Stander","year":"2001","unstructured":"Stander S, Szepfalusi Z, Bohle B, Stander H, Kraft D, Luger TA, Metze D (2001) Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell Tissue Res 304:261\u2013269","journal-title":"Cell Tissue Res"},{"key":"2863_CR64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2006.00657.x","volume":"77","author":"M Schmidt-Hieber","year":"2006","unstructured":"Schmidt-Hieber M, Loddenkemper C, Schwartz S, Arntz G, Thiel E, Notter M (2006) Hydrops lysosomalis generalisatus\u2013an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 77:83\u201385","journal-title":"Eur J Haematol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-013-2863-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-013-2863-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-013-2863-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T20:28:28Z","timestamp":1562704108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-013-2863-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,22]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1007\/s00134-013-2863-6","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,22]]}}}